104 related articles for article (PubMed ID: 7166185)
21. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
[TBL] [Abstract][Full Text] [Related]
22. [Pharmacokinetics and metabolism of trazodone in man (author's transl)].
Jauch R; Kopitar Z; Prox A; Zimmer A
Arzneimittelforschung; 1976; 26(11):2084-9. PubMed ID: 1037253
[TBL] [Abstract][Full Text] [Related]
23. [Gas chromatographic method for determining N-propylajmalin bitartrate in human plasma (author's transl)].
Thoma M; Farinello L; Müller A
Arzneimittelforschung; 1981; 31(6):1020-1. PubMed ID: 7196232
[No Abstract] [Full Text] [Related]
24. [Pharmacokinetics and biotransformation of the analgesic flupirtine in the rat and dog].
Obermeier K; Niebch G; Thiemer K
Arzneimittelforschung; 1985; 35(1):60-7. PubMed ID: 4039153
[TBL] [Abstract][Full Text] [Related]
25. [Pharmacokinetics and metabolite pattern of clenbuterol in the rat].
Kopitar Z; Zimmer A
Arzneimittelforschung; 1976; 26(7a):1435-41. PubMed ID: 1036935
[TBL] [Abstract][Full Text] [Related]
26. Metabolism and pharmacokinetics of the dihydropyridine calcium antagonist, ryosidine, in man.
Midgley I; Chasseaud LF; Taylor IW; Walmsley LM; Fowkes AG; Darragh A; Lambe RF; Bonn R
Xenobiotica; 1985 Nov; 15(11):965-77. PubMed ID: 4082636
[TBL] [Abstract][Full Text] [Related]
27. Metabolism and excretion of ropivacaine in humans.
Halldin MM; Bredberg E; Angelin B; Arvidsson T; Askemark Y; Elofsson S; Widman M
Drug Metab Dispos; 1996 Sep; 24(9):962-8. PubMed ID: 8886605
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
Mukai H; Sugimoto T; Ago M; Morino A
Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
[TBL] [Abstract][Full Text] [Related]
29. On the pharmacokinetics and metabolism of propiverine in man.
Haustein KO; Hüller G
Eur J Drug Metab Pharmacokinet; 1988; 13(2):81-90. PubMed ID: 3208795
[TBL] [Abstract][Full Text] [Related]
30. Column liquid chromatographic determination of prajmalium in plasma and urine by direct sample injection.
Padrini R; Piovan D; Moretto R
J Chromatogr; 1987 Mar; 415(1):183-7. PubMed ID: 3584355
[No Abstract] [Full Text] [Related]
31. [Pharmacokinetics and biotransformation of the analgesic flupirtine in humans].
Hlavica P; Niebch G
Arzneimittelforschung; 1985; 35(1):67-74. PubMed ID: 4039154
[TBL] [Abstract][Full Text] [Related]
32. Metabolism, kinetics and metabolic activity of the beta-cytotropic antidiabetic 4-(5-isobutylpyrimidinyl-2)-sulphamylphenylacetic acid-3-chloro-6-methoxyanilide sodium (glydanile sodium) in man after oral and intravenous administration.
Gerhards E; Berger D; Peters S
Arzneimittelforschung; 1976 Feb; 26(2):278-86. PubMed ID: 947213
[TBL] [Abstract][Full Text] [Related]
33. Absorption and excretion of a new antidepressive (SQ 10,996) in humans.
Vukovich RA; Dreyfuss J; Schreiber EC; Neiss ES
Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):182-6. PubMed ID: 950260
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of [14C]-labelled Losigamone and enantiomers after oral administration to healthy subjects.
Peeters PA; Van Lier JJ; Van De Merbel N; Oosterhuis B; Wieling J; Jonkman JH; Klessing K; Biber A
Eur J Drug Metab Pharmacokinet; 1998; 23(1):45-53. PubMed ID: 9625272
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and metabolism of 14C-labelled alinidine in man and dogs.
Arndts D; Leb G; Förster HJ
Eur J Drug Metab Pharmacokinet; 1981; 6(3):225-36. PubMed ID: 7308242
[TBL] [Abstract][Full Text] [Related]
36. The pharmacokinetics of tetroxoprim in the dog.
Vergin H; Strobel K
Eur J Drug Metab Pharmacokinet; 1982; 7(3):197-202. PubMed ID: 7173274
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of pirazolac--a new anti-inflammatory drug--in human volunteers. I. Absorption, disposition, biotransformation and excretion.
Täuber U; Weiss C; Krause W; Acksteiner B; Matthes H
Eur J Drug Metab Pharmacokinet; 1985; 10(1):41-53. PubMed ID: 4029220
[TBL] [Abstract][Full Text] [Related]
38. Disposition and pharmacokinetics of cadralazine and individual metabolites in man.
Schütz H; Faigle JW; Küng W; Theobald W
Eur J Drug Metab Pharmacokinet; 1985; 10(2):147-53. PubMed ID: 4043143
[TBL] [Abstract][Full Text] [Related]
39. [Studies on pharmacokinetics and biotransformation of ipratropiumbromide in man (author's transl)].
Adlung J; Höhle KD; Zeren S; Wahl D
Arzneimittelforschung; 1976; 26(5a):1005-10. PubMed ID: 134721
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and biotransformation of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S, 5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498) in rat, dog and man.
Eckert HG; Badian MJ; Gantz D; Kellner HM; Volz M
Arzneimittelforschung; 1984; 34(10B):1435-47. PubMed ID: 6097271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
